======= FOXN3 =======
== Gene Information ==
* **Official Symbol**: FOXN3
* **Official Name**: forkhead box N3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1112|1112]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O00409|O00409]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=FOXN3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FOXN3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602628|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Acts as a transcriptional repressor. May be involved in DNA damage-inducible cell cycle arrests (checkpoints). {ECO:0000269|PubMed:16102918}.
|Fork head|
|mitotic G2 DNA damage checkpoint|
|craniofacial suture morphogenesis|
|mitotic G2/M transition checkpoint|
|G2 DNA damage checkpoint|
|cranial skeletal system development|
|negative regulation of G2/M transition of mitotic cell cycle|
|mitotic DNA damage checkpoint|
|negative regulation of cell cycle G2/M phase transition|
|mitotic DNA integrity checkpoint|
|bone morphogenesis|
|DNA damage checkpoint|
|DNA integrity checkpoint|
|mitotic cell cycle checkpoint|
|protein C-terminus binding|
|cell cycle checkpoint|
|regulation of G2/M transition of mitotic cell cycle|
|bone development|
|regulation of cell cycle G2/M phase transition|
|negative regulation of mitotic cell cycle phase transition|
|negative regulation of cell cycle phase transition|
|skeletal system morphogenesis|
|negative regulation of mitotic cell cycle|
|negative regulation of cell cycle process|
|regulation of mitotic cell cycle phase transition|
|sequence-specific DNA binding|
|regulation of cell cycle phase transition|
|skeletal system development|
|negative regulation of cell cycle|
|mitotic cell cycle process|
|regulation of mitotic cell cycle|
|mitotic cell cycle|
|regulation of cell cycle process|
|cellular response to DNA damage stimulus|
|animal organ morphogenesis|
|cell cycle process|
|regulation of cell cycle|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|cell cycle|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|cellular response to stress|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp537|WNT3A 44ng/ml R08 exp537]]|-1.82|
|[[:results:exp472|CI-1040 9.5μM R08 exp472]]|-1.72|
|[[:results:exp85|UM0129480 7μM R02 exp85]]|2.08|
|[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|2.15|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5198
* **Expression level (log2 read counts)**: 6.65
{{:chemogenomics:nalm6 dist.png?nolink |}}